Keywords: لانینامیفیر; Influenza; Laninamivir; Neuraminidase inhibitor; Fever; Symptom;
مقالات ISI لانینامیفیر (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: لانینامیفیر; Influenza; Laninamivir; Neuraminidase inhibitor; Fever; Symptom;
Keywords: لانینامیفیر; Influenza; Laninamivir; Neuraminidase inhibitor; Fever; Symptom
Keywords: لانینامیفیر; NA; neuraminidase; IC50; amount of drug to reduce enzyme activity by 50%; ELISA; enzyme linked immunosorbent assay; Influenza; Laninamivir; Resistance; Enzyme kinetics;
Keywords: لانینامیفیر; Laninamivir; Influenza; Powder delivery; Ferrets; Antiviral; Neuraminidase inhibitor;
Keywords: لانینامیفیر; Long-acting neuraminidase inhibitor; Laninamivir; Effectiveness; IC50
Keywords: لانینامیفیر; Long-acting neuraminidase inhibitor; Laninamivir; Efficacy; IC50
Keywords: لانینامیفیر; Long-acting neuraminidase inhibitor; Laninamivir; Efficacy; IC50;
Keywords: لانینامیفیر; MDCK; Madin-Darby canine kidney; FBS; fetal bovine serum; PBS; phosphate buffered saline; BSA; bovine serum albumin; pfu; plaque forming unit; MLD50; 50% mouse lethal dose; hpi; hours postinfection; dpi; days postinfection; MRT; mean residence time; hal
Keywords: لانینامیفیر; Laninamivir; Neuraminidase inhibitor; Influenza; Prophylaxis; Post-exposure; Household contact;
Clinical effectiveness of four neuraminidase inhibitors (oseltamivir, zanamivir, laninamivir, and peramivir) for children with influenza A and B in the 2014-2015 to 2016-2017 influenza seasons in Japan
Keywords: لانینامیفیر; Oseltamivir; Zanamivir; Laninamivir; Peramivir; Influenza A; Influenza B;
In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2015-16 season: Comparison with the 2010-11 to 2014-15 seasons
Keywords: لانینامیفیر; Influenza; 50% inhibitory concentration; Oseltamivir; Zanamivir; Laninamivir; Peramivir;
In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012–2013 season
Keywords: لانینامیفیر; Influenza; 50% inhibitory concentration; Oseltamivir; Zanamivir; Laninamivir; Peramivir
In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of the influenza virus circulating in the Japanese 2013–2014 season
Keywords: لانینامیفیر; Influenza; 50% Inhibitory concentration; Oseltamivir; Zanamivir; Laninamivir; Peramivir
In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against influenza virus isolates in the 2011–2012 season in Japan
Keywords: لانینامیفیر; Influenza; 50% Inhibitory concentration; Oseltamivir; Zanamivir; Laninamivir; Peramivir
Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009–2010 and 2010–2011 influenza seasons in Japan
Keywords: لانینامیفیر; Influenza; Half maximal inhibitory concentration (IC50); Oseltamivir; Zanamivir; Peramivir; Laninamivir
High and continuous exposure of laninamivir, an anti-influenza drug, may work suppressively to generate low-susceptibility mutants in animals
Keywords: لانینامیفیر; Laninamivir; CS-8958; Influenza; Long-acting neuraminidase inhibitor; Low-susceptibility mutant in vivo;
Binding pattern of the long acting neuraminidase inhibitor laninamivir towards influenza A subtypes H5N1 and pandemic H1N1
Keywords: لانینامیفیر; Laninamivir; Neuraminidase; H5N1; Pandemic H1N1; Molecular dynamics simulation
Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance
Keywords: لانینامیفیر; Laninamivir; Safety; Abnormal behaviour; Post-marketing surveillance
Widespread use of neuraminidase inhibitors in Japan
Keywords: لانینامیفیر; Influenza; Pandemic; Neuraminidase inhibitor; Peramivir; Laninamivir; Oseltamivir; Zanamivir;